-
China's pharmaceutical industry in 2022: these keywords & hot events
Time of Update: 2023-02-03
"Heavy blow"Fortunately, the journey of twists and turns is accompanied by a ray of hope: in November 2022, Henlius' Hans-like (serplulimab) bridging study in the United States completed the first drug administration; In December, EMA accepted Junshi Tuoyi's marketing authorization application; East China Pharmaceutical, Tonghua Dongbao Liraglutide injection have comprehensively expanded into emerging countries such as the Middle East and North Africa.
-
What is the development prospect of China's pharmaceutical equipment industry in 2023? Industry: will usher in an upward cycle
Time of Update: 2023-02-01
From the perspective of the development environment of the pharmaceutical equipment industry, in terms of policy environment, with the continuous improvement of the medical system reform and social security mechanism, the policy is continuing to support and encourage the high-quality development of the domestic pharmaceutical equipment industry, especially the high-end pharmaceutical equipment industry.
-
China's exports of industrial products increased by nearly 10%! The international market has become
Time of Update: 2023-02-01
Pharmaceutical machine industry (Image source: Pharmaceutical Network) The international market has become an important market for the layout of pharmaceutical machine enterprises Canaan Technology said on the investor interactive platform on January 9 that the international market is an important market for the company's business, and the company will pay close attention to relevant policy notices and market dynamics.
-
What is the difference between innovation in China's pharmaceutical industry and multinational companies?
Time of Update: 2022-11-15
Second, leading Chinese pharmaceutical companies that have historically focused on generic drugs can take advantage of their ample funding and management capabilities to develop more novel drugs for less risky and more mature drug targets, and become more competitive with multinational companies in terms of the number of clinical-stage products.
-
Shao Liming's team published an opinion piece in the journal Nat Rev Drug Discov: The Innovation Landscape of China's Pharmaceutical Industry
Time of Update: 2022-11-15
Recently, Shao Liming, professor of the School of Pharmacy of Fudan University and director of the Shanghai Collaborative Innovation Center for Drug R&D, and his team published a review article entitled "Innovation in the Chinese pharmaceutical industry" in the journal Nature Review Drug Discovery, which clearly shows the current situation of innovation and research and development in China's pharmaceutical industry.
-
In the first 10 months, China's exports increased by 13% year-on-year, how did the pharmaceutical equipment industry perform?
Time of Update: 2022-11-11
【Pharmaceutical Network Market Analysis】On November 7, the General Administration of Customs released data showing that in the first 10 months of this year, China's total import and export value was 3
-
The development of China's pharmaceutical industry is analyzed from the differences in biotech commercialization models between China and the United States
Time of Update: 2022-10-25
Policy Research Center, China Association for the Promotion of Pharmaceutical Innovation Policy Research Center, China Association for the Promotion of Pharmaceutical Innovation Author: Zhang Yangyan
-
Digital intelligence empowers Zhangshu, the "pharmaceutical capital of China" The annual revenue of the pharmaceutical industry exceeds 100 billion yuan
Time of Update: 2022-10-25
"We strive to build Geshushan Mountain Area into a national 5A-level tourist attraction in five years, develop a number of tourism commodities, traditional Chinese medicine meals and health foods with the characteristics of the medicine capital, and enhance the tourism image of 'China's medicine capital and health blessing land'.
-
China's first continuous manufacturing guide is coming, and the pharmaceutical industry will usher in major changes!
Time of Update: 2022-10-19
In order to encourage innovation and pharmaceutical modernization, help the implementation of the ICH Q13 guiding principles in China, and also guide enterprise research and development, unified eval
-
The first continuous manufacturing guide in China is coming, and the pharmaceutical industry will usher in major changes!
Time of Update: 2022-10-13
In order to encourage innovation and pharmaceutical modernization, to help the implementation of the ICH Q13 guidelines in China, but also to guide enterprises in research and development, unified re
-
The first continuous manufacturing guide in China is coming, and the pharmaceutical industry will usher in major changes!
Time of Update: 2022-10-13
In order to encourage innovation and pharmaceutical modernization, to help the implementation of the ICH Q13 guidelines in China, but also to guide enterprises in research and development, unified re
-
Recommend the map of innovation and development of China's pharmaceutical and health industry
Time of Update: 2022-09-09
Figure 1: Distribution of listed pharmaceutical and health enterprises nationwide as of July 31, 2022 Source: Flint Creation Industry Data Center From the perspective of the segmentation of listed enterprises, listed biomedical companies are mainly concentrated in Beijing, Shanghai, Jiangsu, Guangdong and other regions.
-
2022 China Pharmaceutical Industry Technology Annual Conference Schedule Update!
Time of Update: 2022-09-06
All relevant units: In order to implement the "14th Five-Year Plan" development plan of the national pharmaceutical industry, promote the innovation-driven transformation of the pharmaceutical industr
-
Summary of the top ten development trends of China's pharmaceutical industry in 2021
Time of Update: 2022-08-15
Relying on the data resources of Medicine Cube China and the entire pharmaceutical industry chain, we have summarized ten trends in the development of the Chinese medicine industry in the past year, covering many fields such as drug research and development, innovative technologies/therapies, major policies, investment and financing , etc.
-
China's pharmaceutical and life sciences industry M&A transaction volume hits record high in 2021
Time of Update: 2022-05-25
The report predicts that China's aging population and the impact of the new crown epidemic will continue to increase market demand in the pharmaceutical and life science industries, and the long-term trend will remain positive .
